RxDoctor Payments DataLook up a doctor →

Ernie Riffer, MD

Internal Medicine · Phoenix, AZNPI 1134284268

Payments from drug & device makers

$2,956,647in general payments, 2019–2025

Across 1,458 payments — averaging $2027.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Janssen Research & Development, LLC$984K
  • Novo Nordisk AS$576K
  • Valneva Austria GmbH$349K
  • AbbVie$243K
  • Sanofi US Services Inc.$209K
  • Regeneron$162K
  • plus $434K from 37 others
$212,676in research payments, 2019–2025

Across 5 payments — averaging $42,535 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Valneva Austria GmbH$204K
  • Eli Lilly$9K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,956,647 in reported general payments places this provider in the 95th percentile of 2,212 internal medicine providers in Arizona.

See all internal medicine providers in Arizona

Medicare billing

Part B allowed, 2024
$95,934
Medicare patients
345
Services billed
993

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other internal medicine in Phoenix

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →